Mobile app developer adds disease-specific modules for patients – and pharma partners
While pharma companies have struggled to gain traction with mobile apps for patients, one developer is working on a way to help. Smartpatient is launching disease-specific modules for its MyTherapy app — with pharma partnerships.
The first add-on, MyTherapy MS, debuted last week with 1,000 multiple sclerosis patients already using it through a trial in Germany. Smartpatient plans to expand the MS module to Europe and the US later while also lining up more disease-specific modules for asthma, psoriasis, rheumatoid arthritis and HIV for debut over the next few months.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
